The global hemodynamic monitoring market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). Hemodynamic monitoring is often employed in critical care settings, cardiac surgery, anesthesia management, emergency medicine, perioperative care, and heart failure management. This monitoring helps assess and guide interventions related to cardiovascular function. Parameters such as cardiac output, stroke volume, mean arterial pressure, and systemic vascular resistance are monitored to ensure stability and optimize patient care. It is a medical procedure used for research, clinical trials, remote patient monitoring, and renal care. It involves the assessment of various cardiac parameters, such as cardiac output, blood pressure, and perfusion. Furthermore, the market’s growth is attributed to the technological advancement across the globe. Integration of modern sensors and technologies, such as the FloTracTM integration, helps to drive the market's expansion. For instance, in June 2023, Mindray Medical, collaborated with Edwards Lifesciences, This latest milestone provides a solution that integrates Edwards FloTracTM sensor for hemodynamic monitoring into Mindray's flagship BeneVision N series patient monitors. FloTracTM sensor is a monitoring device used for hemodynamically unstable patients. It is connected to an arterial line and provides key pressure and flow parameters every 20 seconds, such as CO, SV, SVV, SVR, and MAP. This helps to guide appropriate treatment.
Browse the full report description of “Hemodynamic Monitoring Market Size, Share & Trends Analysis Report by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems, and others), by Product (Disposables and Monitors), and by End-User (Hospitals, Clinics & Ambulatory Care Centers, Ambulatory Care Centers, Home Care Settings, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/hemodynamic-monitoring-market
Furthermore, as the global population ages, there is an increased need for hemodynamic monitoring owing to the higher incidence of cardiovascular issues. in October 2020, Getinge launched NICCI the latest innovation in Advanced Hemodynamic Monitoring. Advanced Hemodynamic Monitoring is an innovation that provides continuous and noninvasive hemodynamic insights to lower the risk of serious consequences in patients with low blood pressure.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By System
o By Product
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Deltex Medical Ltd., Dräger, Edwards Lifesciences Corp., GE HealthCare Technologies Inc., Getinge AB and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Hemodynamic Monitoring Market Report Segment
By System
By Product
By End-User
Global Hemodynamic Monitoring Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hemodynamic-monitoring-market